Pengfei Zhang

Pengfei Zhang

Auto-generated profile, based on publicly available information

Pengfei Zhang

Department of Industrial and Manufacturing Systems Engineering, Kansas State University, Manhattan, KS 66506

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 December 2021 in Journal of Nanobiotechnology
Verified
Journal Article
Open access
PDF file
YWYuye Wu
Yuye Wu
DBDheerendranath Battalapalli
Dheerendranath Battalapalli
MHMohammed J. Hakeem
Mohammed J. Hakeem
VSVenkatarao Selamneni
Venkatarao Selamneni
PZPengfei Zhang
Pengfei Zhang
ZRZhi Ruan
Zhi Ruan
Antibiotic resistance is spreading rapidly around the world and seriously impeding efforts to control microbial infections. Although nucleic acid testing is widely deployed for the detection of antibiotic resistant bacteria, the current techniques—mainly based on polymerase chain reaction (PCR)—are time-consuming and laborious. There is an urgent need to develop new strategies to control bacterial infections and the spread of antimicrobial resistance (AMR). The CRISPR-Cas system is an adaptive immune system found in many prokaryotes that presents attractive opportunities to target and edit nucleic acids with high precision and reliability. Engineered CRISPR-Cas systems are reported to effectively kill bacteria or even revert bacterial resistance to antibiotics (resensitizing bacterial cells to antibiotics). Strategies for combating antimicrobial resistance using CRISPR (i.e., Cas9, Cas12, Cas13, and Cas14) can be of great significance in detecting bacteria and their resistance to antibiotics. This review discusses the structures, mechanisms, and detection methods of CRISPR-Cas systems and how these systems can be engineered for the rapid and reliable detection of bacteria using various approaches, with a particular focus on nanoparticles. In addition, we summarize the most recent advances in applying the CRISPR-Cas system for virulence modulation of bacterial infections and combating antimicrobial resistance. Graphical Abstract

22 December 2023 in Analytical Chemistry
Verified
Journal Article
Closed access
LFLingzhi Fan
Lingzhi Fan
WYWannian Yan
Wannian Yan
QCQilong Chen
Qilong Chen
FTFei Tan
Fei Tan
YTYijie Tang
Yijie Tang
PZPengfei Zhang
Pengfei Zhang

1 September 2015 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
PZPengfei Zhang
Pengfei Zhang
YBYan Bao
Yan Bao
MDMohamed Shehata Draz
Mohamed Shehata Draz
HLHuiqi Lu
Huiqi Lu
CLChang Liu
Chang Liu
HHHuanxing Han
Huanxing Han
Convenient and rapid immunofiltration assays (IFAs) enable on-site “yes” or “no” determination of disease markers. However, traditional IFAs are commonly qualitative or semi-quantitative and are very limited for the efficient testing of samples in field diagnostics. Here, we overcome these limitations by developing a quantum dots (QDs)-based fluorescent IFA for the quantitative detection of C-reactive proteins (CRP). CRP, the well-known diagnostic marker for acute viral and bacterial infections, was used as a model analyte to demonstrate performance and sensitivity of our developed QDs-based IFA. QDs capped with both polyethylene glycol (PEG) and glutathione were used as fluorescent labels for our IFAs. The presence of the surface PEG layer, which reduced the non-specific protein interactions, in conjunction with the inherent optical properties of QDs, resulted in lower background signal, increased sensitivity, and ability to detect CRP down to 0.79 mg/L with only 5 µL serum sample. In addition, the developed assay is simple, fast and can quantitatively detect CRP with a detection limit up to 200 mg/L. Clinical test results of our QD-based IFA are well correlated with the traditional latex enhance immune-agglutination aggregation. The proposed QD-based fluorescent IFA is very promising, and potentially will be adopted for multiplexed immunoassay and in field point-of-care test.

13 April 2023 in Applied Microbiology and Biotechnology
Verified
Journal Article
Closed access
PDF file
XZXiaoqin Zhong
Xiaoqin Zhong
QFQiaoting Fu
Qiaoting Fu
YWYaoqun Wang
Yaoqun Wang
LLLan Long
Lan Long
WJWencheng Jiang
Wencheng Jiang
FTFei Tan
Fei Tan

23 April 2021 in Journal of Nanobiotechnology
Verified
Journal Article
Open access
PDF file
PZPengfei Zhang
Pengfei Zhang
MDMohamed S. Draz
Mohamed S. Draz
AXAnwen Xiong
Anwen Xiong
WYWannian Yan
Wannian Yan
HHHuanxing Han
Huanxing Han
WCWansheng Chen
Wansheng Chen
Background: Highly efficient capture and detection of circulating tumor cells (CTCs) remain elusive mainly because of their extremely low concentration in patients’ peripheral blood. Methods: We present an approach for the simultaneous capturing, isolation, and detection of CTCs using an immuno-fluorescent magnetic nanobead system (iFMNS) coated with a monoclonal anti-EpCAM antibody. Results: The developed antibody nanobead system allows magnetic isolation and fluorescent-based quantification of CTCs. The expression of EpCAM on the surface of captured CTCs could be directly visualized without additional immune-fluorescent labeling. Our approach is shown to result in a 70–95% capture efficiency of CTCs, and 95% of the captured cells remain viable. Using our approach, the isolated cells could be directly used for culture, reverse transcription-polymerase chain reaction (RT-PCR), and immunocytochemistry (ICC) identification. We applied iFMNS for testing CTCs in peripheral blood samples from a lung cancer patient. Conclusions: It is suggested that our iFMNS approach would be a promising tool for CTCs enrichment and detection in one step. Graphic

1 November 2024 in ACS Applied Bio Materials
Verified
Journal Article
Closed access
XTXinyue Tang
Xinyue Tang
WXWenwen Xia
Wenwen Xia
HHHuanxing Han
Huanxing Han
YWYucheng Wang
Yucheng Wang
BWBolong Wang
Bolong Wang
PZPengfei Zhang
Pengfei Zhang